意见反馈

INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC IN RESPECT OF FULLCIRCULATION OF THE SHARES BY THE COMPANY

2024-07-03 00:00:00

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.INSIDE INFORMATION ISSUANCE OF FILING NOTICE BY THE CSRC IN RESPECT OF FULL CIRCULATION OF THE SHARES BY THE COMPANY This announcement is made by Wenzhou Kangning Hospital Co. Ltd. (the “Company”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) and Part XIVA of the Securities and Futures Ordinance.Reference is made to the announcement of the Company dated April 26 2024 (the “Announcement”) in relation to among other things the application for the full circulation of the shares by the Company. Unless otherwise defined capitalised terms used herein shall have the same meanings as those defined in the Announcement.The Company has recently submitted the filing with the CSRC in relation to the implementation of full circulation of the shares by the Company. The board of directors (the “Board”) of the Company is pleased to announce that the CSRC published a filing notice (the “Filing Notice”) on its website in relation to the full circulation of the shares by the Company on June 28 2024 and confirmed the relevant information and the filing application for the conversion and listing has been completed. According to the Filing Notice if the Company fails to complete share conversion within 12 months from the date of issuance of the Filing Notice the Company shall submit updated filing materials with the CSRC if it intends to proceed with it.Please refer to the Announcement for names of Shareholders participating in the full circulation of the shares and relevant details.The shareholding structure of the Company before and upon the completion of the conversion and listing is set out as follows: Before the completion of the Upon the completion of the conversion and listing conversion and listing Approximate Approximate percentage of percentage of total issued total issued Number of shares of the Number of shares of the Class of shares shares Company shares Company Domestic shares 55260000 74.07% 52760000 70.72% H shares 19340300 25.93% 21840300 29.28% Total 74600300 100% 74600300 100% 1As of the date of this announcement details of the implementation plan of the full circulation and the conversion and listing of the shares have not been finalized. The Company will make further announcement(s) on the progress of the full circulation and the conversion and listing of the shares as and when appropriate.The full circulation and the conversion and listing of the shares are subject to other relevant procedures as required by the Stock Exchange and other domestic and overseas regulatory authorities. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the shares of the Company.By order of the Board Wenzhou Kangning Hospital Co. Ltd.GUAN Weili Chairman Zhejiang the PRC July 3 2024 As of the date of this announcement the Company’s executive Directors are Mr. GUAN Weili Ms.WANG Lianyue and Mr. WANG Jian; the non-executive Directors are Mr. QIN Hao and Mr. LI Changhao; and the independent non-executive Directors are Ms. ZHONG Wentang Ms. JIN Ling and Mr. CHAN Sai Keung Hugo. 2